IL34291A - שיטה לשיפור ייצובם של אנזימים - Google Patents
שיטה לשיפור ייצובם של אנזימיםInfo
- Publication number
- IL34291A IL34291A IL34291A IL3429170A IL34291A IL 34291 A IL34291 A IL 34291A IL 34291 A IL34291 A IL 34291A IL 3429170 A IL3429170 A IL 3429170A IL 34291 A IL34291 A IL 34291A
- Authority
- IL
- Israel
- Prior art keywords
- enzyme
- microwave energy
- blood serum
- exposure
- treated
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title claims description 81
- 108090000790 Enzymes Proteins 0.000 title claims description 81
- 238000000034 method Methods 0.000 title claims description 21
- 210000002966 serum Anatomy 0.000 claims description 29
- 239000002826 coolant Substances 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 11
- 239000012736 aqueous medium Substances 0.000 claims description 9
- 230000006866 deterioration Effects 0.000 claims description 5
- 230000002779 inactivation Effects 0.000 claims description 5
- 229940088598 enzyme Drugs 0.000 description 68
- 239000000463 material Substances 0.000 description 43
- 239000007789 gas Substances 0.000 description 23
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 238000011282 treatment Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 108010065511 Amylases Proteins 0.000 description 6
- 102000013142 Amylases Human genes 0.000 description 6
- 235000019418 amylase Nutrition 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000004382 Amylase Substances 0.000 description 5
- 101710088194 Dehydrogenase Proteins 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 108090000340 Transaminases Proteins 0.000 description 4
- 102000003929 Transaminases Human genes 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 108010044467 Isoenzymes Proteins 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- 108020005199 Dehydrogenases Proteins 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000004071 soot Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 108010009924 Aconitate hydratase Proteins 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010041525 Alanine racemase Proteins 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 102100039868 Cytoplasmic aconitate hydratase Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108010088350 Lactate Dehydrogenase 5 Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 101000574441 Mus musculus Alkaline phosphatase, germ cell type Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 101100203598 Plasmodium falciparum (isolate NF54) SOPT gene Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 102000005396 glutamine synthetase Human genes 0.000 description 1
- 108020002326 glutamine synthetase Proteins 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/13—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultrasonic waves
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81718169A | 1969-04-17 | 1969-04-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL34291A0 IL34291A0 (en) | 1970-06-17 |
| IL34291A true IL34291A (he) | 1973-03-30 |
Family
ID=25222518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL34291A IL34291A (he) | 1969-04-17 | 1970-04-09 | שיטה לשיפור ייצובם של אנזימים |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3645849A (he) |
| AT (1) | AT295453B (he) |
| AU (1) | AU1362570A (he) |
| BE (1) | BE749082A (he) |
| CA (1) | CA920524A (he) |
| CH (1) | CH525914A (he) |
| DE (1) | DE2017571C3 (he) |
| ES (1) | ES378692A1 (he) |
| FR (1) | FR2039250A1 (he) |
| GB (1) | GB1267475A (he) |
| IL (1) | IL34291A (he) |
| NL (1) | NL7005554A (he) |
| SE (1) | SE355817B (he) |
| TR (1) | TR16728A (he) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL58541A (en) * | 1978-11-01 | 1982-02-28 | Nordisk Insulinlab | Antihemophilic factor preparation from human blood plasma and a process for producing it |
| US4250139A (en) * | 1979-02-01 | 1981-02-10 | Collagen Corporation | Microwave sterilization of dry protein |
| US4994237A (en) * | 1987-10-02 | 1991-02-19 | The Beth Israel Hospital Association | Microwave preservation of bioprostheses |
| US5283034A (en) * | 1989-06-29 | 1994-02-01 | Applied Immune Sciences, Inc. | Stabilization of sterilized surfaces for research and medical use |
| CA1340565C (en) | 1989-06-29 | 1999-05-25 | Thomas B. Okarma | Device and process for cell capture and recovery |
| US6143508A (en) * | 1989-06-29 | 2000-11-07 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Device and process for cell capture and recovery |
| US5372149A (en) * | 1992-03-25 | 1994-12-13 | Roth; David S. | Sterilization process in the manufacturing of snuff |
| US5534026A (en) * | 1992-04-02 | 1996-07-09 | The Penn State Research Foundation | Preparation of inexpensive, HIV-free human skin allograft |
| DE69735003T2 (de) * | 1996-01-17 | 2006-07-13 | Tauw B.V. | Verfahren zur aufbereitung einer probe |
| US5730933A (en) * | 1996-04-16 | 1998-03-24 | Depuy Orthopaedics, Inc. | Radiation sterilization of biologically active compounds |
| NL1005028C2 (nl) * | 1997-01-17 | 1998-07-20 | Franciscus Matheus Everaerts | Werkwijze voor het controleren van een enzymreactie. |
| CA2646392A1 (en) * | 2006-03-15 | 2007-09-20 | Promethean Lifesciences, Inc. | Preparation and storage of stable, antimicrobially active materials |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2683682A (en) * | 1950-02-06 | 1954-07-13 | Research Corp | Differential inactivation of enzymes |
| US3006815A (en) * | 1956-08-24 | 1961-10-31 | Fermco Lab Inc | Heat stabilization of enzymes and method |
| US3284301A (en) * | 1963-08-28 | 1966-11-08 | American Cyanamid Co | Plasmin sterilization |
| US3494723A (en) * | 1967-12-05 | 1970-02-10 | Gray Ind Inc | Method and apparatus for controlling microorganisms and enzymes |
-
1969
- 1969-04-17 US US817181A patent/US3645849A/en not_active Expired - Lifetime
-
1970
- 1970-04-07 CA CA079426A patent/CA920524A/en not_active Expired
- 1970-04-08 GB GB06770/70A patent/GB1267475A/en not_active Expired
- 1970-04-08 AU AU13625/70A patent/AU1362570A/en not_active Expired
- 1970-04-09 IL IL34291A patent/IL34291A/he unknown
- 1970-04-13 DE DE2017571A patent/DE2017571C3/de not_active Expired
- 1970-04-14 CH CH552770A patent/CH525914A/fr not_active IP Right Cessation
- 1970-04-15 SE SE05151/70A patent/SE355817B/xx unknown
- 1970-04-16 ES ES378692A patent/ES378692A1/es not_active Expired
- 1970-04-17 NL NL7005554A patent/NL7005554A/xx unknown
- 1970-04-17 AT AT351170A patent/AT295453B/de not_active IP Right Cessation
- 1970-04-17 TR TR16728A patent/TR16728A/xx unknown
- 1970-04-17 BE BE749082D patent/BE749082A/xx unknown
- 1970-04-17 FR FR7014063A patent/FR2039250A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB1267475A (en) | 1972-03-22 |
| AU1362570A (en) | 1971-10-14 |
| FR2039250A1 (he) | 1971-01-15 |
| IL34291A0 (en) | 1970-06-17 |
| DE2017571B2 (de) | 1973-03-01 |
| AT295453B (de) | 1972-01-10 |
| TR16728A (tr) | 1973-03-01 |
| NL7005554A (he) | 1970-10-20 |
| BE749082A (fr) | 1970-10-19 |
| SE355817B (he) | 1973-05-07 |
| CA920524A (en) | 1973-02-06 |
| DE2017571C3 (de) | 1973-10-04 |
| CH525914A (fr) | 1972-07-31 |
| ES378692A1 (es) | 1972-07-16 |
| US3645849A (en) | 1972-02-29 |
| DE2017571A1 (he) | 1970-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3645849A (en) | Stability of enzymes | |
| AU617451B2 (en) | Process for stabilizing human albumin solutions and the solution obtained | |
| US2908614A (en) | Use of dextran in freeze-drying process | |
| US4687664A (en) | Method of inactivating reproducible pathogens | |
| Scherer et al. | Preservation at subzero temperatures of mouse fibroblasts (strain L) and human epithelial cells (strain HeLa). | |
| US4764466A (en) | Method for stabilizing an immobilized fibrinolytic enzyme | |
| DE69922362D1 (de) | Methode zur präparation eines diafiltrierten stabilen blutproduktes | |
| US20030068416A1 (en) | Method of lyophylization to reduce solvent content and enhance product recovery | |
| US6696019B2 (en) | Rapid cryobaric sterilization and vaccine preparation | |
| JP2000511519A (ja) | 生物学的製品の最終滅菌法 | |
| EP1140219A1 (en) | Biotherapeutic virus attenuation using variable frequency microwave energy | |
| Braams | Changes in the radiation sensitivity of some enzymes and the possibility of protection against the direct action of ionizing particles | |
| US3249504A (en) | Multiple unit tissue culture preparation and method of preparing same | |
| Varianytsia et al. | Storage methods of complex RNA viruses | |
| CZ2022116A3 (cs) | Způsob přípravy biologického léčivého přípravku na bázi perinatální tkáně, práškový materiál a jeho použití | |
| JPS61501510A (ja) | ビ−ルスリスクを減らしたヘモグロビンおよびその製造方法 | |
| RU2061755C1 (ru) | СПОСОБ СТАБИЛИЗАЦИИ УЛЬТРАКОНЦЕНТРАТА ГРИБНОЙ β -ГАЛАКТОЗИДАЗЫ | |
| CN101759766B (zh) | 一种动物源可凝固蛋白的制备方法 | |
| KR930019813A (ko) | 막걸리의 제조 및 장기 저장방법 | |
| HOWARD | The role of oxygen in the repair process | |
| Glew | Some effects of ionizing radiations on liquid whole milk and whey protein | |
| JPS6354681B2 (he) | ||
| Ohlsson | Progress in pasteurization and sterilization | |
| Garner et al. | Effect of storage at 5 C on the disc electrophoretic patterns of ovine and bovine seminal proteins | |
| SU1655984A1 (ru) | Способ консервировани вируса инфекционного ринотрахеита |